Jinhai Medical Technology Limited (Jinhai Med Tech) has announced that its board of directors will convene on 27 August 2026 to consider and approve the consolidated interim results for the six months ended 30 June 2026. The board will also deliberate on the declaration of an interim dividend, if deemed appropriate.
The notice, dated 4 August 2026, confirms current board composition of eight members: four executive directors—Chen Guobao (Chairman), Li Bin, Wang Zhenfei and Li Yunping; one non-executive director—Wang Huasheng; and three independent non-executive directors—Yan Jianjun, Fan Yimin and Yang Meihua.
Further details, including any dividend decision, are expected to be disclosed following the board meeting.
Comments